Sunshine Act Reporting for Medical Device Representatives

The Physician Payments Sunshine Act — officially Section 6002 of the Affordable Care Act — created the most significant transparency requirement in the history of the medical device industry. Since 2013, every applicable manufacturer of drugs, devices, biologics, and medical supplies covered by Medicare, Medicaid, or CHIP has been required to report payments and transfers of value to physicians and teaching hospitals to the Centers for Medicare & Medicaid Services (CMS). That data is published on the Open Payments website for anyone to see.

For medical device sales representatives, the Sunshine Act changed the operational reality of the job. Every meal, every consulting payment, every educational grant, every product sample — if it involves a transfer of value from a manufacturer to a physician or teaching hospital, it is potentially reportable. The data is public. Physicians can see what’s reported about them. Journalists, competitors, plaintiff attorneys, and federal investigators can see it too.

This article explains what the Sunshine Act requires, what gets reported, the thresholds and categories that matter, and how device reps should track and manage their interactions to stay compliant and protect their professional relationships.

What the Sunshine Act Requires

The Sunshine Act requires “applicable manufacturers” to report two categories of information to CMS annually:

1. Payments and transfers of value to covered recipients (physicians and teaching hospitals)
2. Physician ownership and investment interests in applicable manufacturers or group purchasing organizations

The reporting obligation falls on the manufacturer, not on the physician or the sales representative. But the data that feeds those reports comes from the field — from the interactions that device reps have with physicians every day. If a rep buys a surgeon lunch, takes a physician to a medical education event, or facilitates a consulting payment, that interaction generates reportable data.

Manufacturers must submit their reports to CMS by March 31 of each year, covering all reportable payments made during the prior calendar year. CMS publishes the data on the Open Payments website (openpaymentsdata.cms.gov) by June 30.

The Sunshine Act does not prohibit any specific payment. It is purely a transparency law. A manufacturer can legally pay a physician $500,000 in consulting fees, and the Sunshine Act simply requires that payment to be reported and published. Whether that payment violates other laws — like the Anti-Kickback Statute — is a separate question. But the transparency creates accountability, and the published data has been used in AKS investigations, malpractice lawsuits, and media reports.

Who Reports and Who Is Reported

Applicable Manufacturers

An “applicable manufacturer” is any entity that manufactures a covered drug, device, biologic, or medical supply for sale in the United States, or that is under common ownership with such an entity and provides assistance or support to that entity’s covered products. This includes device companies and their subsidiaries, affiliates, and, importantly, any entity operating under common ownership that assists in the production, preparation, propagation, compounding, conversion, marketing, promotion, sale, or distribution of covered products.

Applicable Group Purchasing Organizations (GPOs) are also covered by the reporting requirements for physician ownership and investment interests.

Covered Recipients

The Sunshine Act defines two categories of covered recipients:

Physicians. This includes doctors of medicine (MD), doctors of osteopathy (DO), dentists, podiatrists, optometrists, and chiropractors. As of January 2022, the definition was expanded to include physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists, anesthesiologist assistants, and certified nurse midwives. This expansion significantly increased the number of individuals whose interactions with manufacturers must be tracked and reported.

Teaching hospitals. Hospitals that receive graduate medical education (GME) payments or indirect medical education (IME) payments from Medicare. The list of teaching hospitals covered by the Sunshine Act is published by CMS annually.

What About Distributors and Independent Reps?

This is where it gets relevant for the SLR Medical audience. Distributors that do not hold title to or manufacture covered products are not themselves “applicable manufacturers” under the Sunshine Act. However, if a distributor acts on behalf of an applicable manufacturer in making transfers of value to physicians, the manufacturer is still required to report those transfers.

In practice, this means that if an independent device rep or distributor makes payments or provides meals to physicians on behalf of a manufacturer — or with manufacturer funds — the manufacturer must report those transfers. The data collection responsibility flows from the field to the manufacturer through the rep. If you’re a 1099 rep operating under a distribution agreement with a manufacturer, the manufacturer may contractually require you to track and report all transfers of value to covered recipients so they can meet their Sunshine Act obligations.

What Gets Reported: Categories of Payment

The Sunshine Act requires reporting across multiple categories of payment. Each reportable transfer of value must be categorized by the type of payment. The categories include:

• Consulting fees — payments to physicians for consulting services
• Compensation for serving as faculty or as a speaker (non-accredited and accredited CME) — fees paid for speaking at company-sponsored events or accredited continuing education programs
• Honoraria — payments for participation in advisory boards, expert panels, or similar activities
• Gifts — items of value provided without expectation of services in return
• Entertainment — costs of recreation or entertainment provided to physicians
• Food and beverage — meals and refreshments provided in connection with business interactions
• Travel and lodging — transportation and accommodation costs provided to physicians
• Education — costs of educational materials or programs provided to physicians
• Research — payments associated with research activities, clinical trials, or investigator-initiated studies
• Charitable contributions — donations to physician-controlled charitable organizations
• Royalty or license — payments for intellectual property rights
• Current or prospective ownership or investment interest — stock, stock options, or other ownership interests
• Grant — funding for research, education, or other purposes
• Space rental or facility fees — payments for use of physician-owned or controlled spaces

Each reported payment must include: the name and address of the covered recipient, the amount of the payment, the date of the payment, a description of the form of payment, the nature of the payment (the category above), and the covered drug, device, or biologic associated with the payment (if applicable).

Reporting Thresholds

The Sunshine Act originally included a de minimis threshold: transfers of value below $10 individually or $100 in aggregate per physician per year were not required to be reported. This threshold was adjusted for inflation and, as of recent reporting years, sits at approximately $11.94 individually and $119.41 in aggregate (these figures are updated annually by CMS).

In practice, most manufacturers report all transfers of value regardless of the threshold. The administrative burden of tracking against the threshold — particularly for food and beverage in group settings — is often greater than the burden of simply reporting everything. If you provide a physician with a $12 lunch, it is likely being reported.

The aggregate threshold is particularly important. Even if individual transfers are below the individual threshold, once the total for a given physician exceeds the aggregate threshold in a calendar year, all transfers to that physician (including those previously below the individual threshold) become reportable. This effectively means that any ongoing professional relationship involving regular meals or small transfers of value will exceed the aggregate threshold and trigger full reporting.

The Open Payments Database

All reported data is published on the CMS Open Payments website (openpaymentsdata.cms.gov). The database is searchable by physician name, manufacturer, and payment category. Anyone can access it — patients, journalists, researchers, attorneys, competitors, and investigators.

The database contains billions of dollars in reported payments. In a typical year, medical device and pharmaceutical manufacturers report over $10 billion in total payments to physicians and teaching hospitals. The data has been used in media investigations of physician-industry financial relationships, academic research on prescribing patterns and financial conflicts of interest, and legal proceedings.

For device reps, the practical implication is that your interactions with physicians are documented in a public record. When you buy a surgeon lunch, it shows up in the database with the physician’s name, your manufacturer’s name, the date, the amount, and the category. This is not something to fear if your interactions are legitimate and properly documented. But it means there is no practical privacy around physician-manufacturer financial interactions.

The Physician Review and Dispute Process

Before the data is published, CMS provides a review period during which physicians can review the payments reported about them, confirm their accuracy, and dispute any entries they believe are incorrect. The review period typically runs from mid-April through mid-May.

Disputes are common. Physicians may not recall a specific meal or may disagree with the attribution of a payment. The manufacturer must respond to disputes and either confirm or correct the reported data. If the dispute is not resolved during the review period, both the manufacturer’s reported data and the physician’s dispute are published.

Device reps should be aware that physicians increasingly check their Open Payments profiles. A surgeon who sees a reported meal they don’t remember, or a payment attributed to a consulting service they didn’t perform, will have questions — and those questions will come back to the rep who documented the interaction. Accurate, contemporaneous recording of transfers of value protects both the rep and the physician.

The Device Rep’s Role in Reporting

While the reporting obligation legally falls on the manufacturer, the device sales representative is the primary data source. In practice, the rep’s role includes:

Capturing data in real time. When you buy a physician lunch, you need to record: which physicians attended, the date, the location, the total cost, the per-physician allocation (if it was a group meal), and the business purpose. This data feeds the manufacturer’s Sunshine Act report.

Accurate physician identification. Transfers must be attributed to the correct physician using their National Provider Identifier (NPI) or other identifying information. In group settings, you need to identify each covered recipient present, not just the primary contact.

Timely submission to compliance. Most manufacturers require reps to submit their transfer-of-value data through a compliance reporting system (usually a web portal or mobile app) within a specified timeframe — often within 5-10 business days of the interaction. Late or incomplete submissions create compliance gaps and reporting inaccuracies.

Group meal allocation. When meals are provided to a group that includes physicians, the cost must be allocated to each covered recipient present. If you bring lunch for a surgical team of 15 people and 3 of them are physicians, the per-physician cost is what gets reported, not the total cost of the lunch. The allocation method (dividing total cost by number of attendees) must be consistent and defensible.

For independent representatives exploring consulting and distribution opportunities, understanding these data collection responsibilities is part of the professional baseline. Manufacturers expect their channel partners to maintain Sunshine Act-compliant tracking systems.

Tracking Systems and Best Practices

Accurate Sunshine Act compliance requires a systematic approach to tracking transfers of value. Here are best practices:

Use the manufacturer’s tracking system. Most manufacturers provide a mobile app or web portal for reps to log meals, educational events, and other transfers of value. Use it consistently. Do not maintain a parallel tracking system that may diverge from the official record.

Record interactions immediately. Memory fades. Record the details of every physician interaction involving a transfer of value on the same day it occurs. Waiting days or weeks to log interactions introduces errors — wrong dates, wrong attendees, wrong amounts.

Keep receipts. Retain receipts for all meals, travel, and other expenses associated with physician interactions. Receipts are the documentary backup if a reported payment is disputed or questioned.

Confirm attendee lists for group events. For meals and educational events with multiple attendees, collect or confirm the names and NPIs of all covered recipients present. Sign-in sheets at educational events serve this purpose and create a contemporaneous record.

Separate personal and business expenses. If you take a physician to lunch and a non-physician colleague joins, the reportable amount is the physician’s portion, not the entire bill. Clean separation of personal and business expenses prevents overreporting and underreporting.

Understand product attribution. Each reported payment may need to be associated with a specific covered product. If the lunch was in connection with a discussion about a specific implant system, that product should be attributed. If the discussion covered multiple product lines, attribution may follow the manufacturer’s internal policies.

Common Mistakes and How to Avoid Them

Forgetting to log small meals. A $15 coffee and sandwich still counts toward the aggregate threshold. If you routinely provide small meals or refreshments to physicians without logging them, you’re creating inaccurate reports. Track everything.

Incorrect physician identification. Reporting a payment under the wrong physician name or NPI creates false records that the physician will dispute. Verify the identity of covered recipients, especially in group settings where you may not know everyone at the table.

Missing the expanded definition of covered recipients. Since 2022, nurse practitioners, physician assistants, CRNAs, and other non-physician practitioners are covered recipients. If you buy lunch for a CRNA who manages your implant inventory in the OR, that interaction is now reportable. Many reps operating on pre-2022 habits are not tracking these interactions.

Failing to report transfers through third parties. If you pay a restaurant for a meal and the physician picks it up later, that is still a transfer of value from you (on behalf of your manufacturer) to the physician. The fact that the transfer was indirect does not eliminate the reporting obligation.

Not understanding what your manufacturer reports. Some reps are surprised when a physician calls to ask about a reported payment they don’t remember. Know what your manufacturer is reporting and be prepared to explain it if a physician has questions.

Sunshine Act vs Anti-Kickback Statute

The Sunshine Act and the Anti-Kickback Statute are related but distinct laws, and confusing them is a common error.

The Sunshine Act is a transparency/disclosure law. It requires reporting of payments but does not prohibit any specific payment. You can legally pay a physician $50,000 in consulting fees; you just have to report it.

The Anti-Kickback Statute is a prohibition law. It makes certain payments illegal — specifically, payments intended to induce referrals of items or services covered by federal healthcare programs. AKS violations carry criminal penalties.

The connection: Sunshine Act data creates a public record that can trigger AKS investigations. When the OIG or DOJ sees that a high-prescribing physician received $200,000 in consulting payments from a manufacturer whose products that physician ordered, the Sunshine Act data becomes evidence in an AKS inquiry. Transparency does not equal compliance. Reporting a payment accurately does not make it legal if the payment itself violates the AKS.

Device reps should understand both laws and recognize that they operate on different axes. The Sunshine Act asks: “Did you report it?” The AKS asks: “Should you have paid it at all?”

For additional compliance context, see our guide to FDA medical device classification, which covers the regulatory framework that determines how the products behind these payments are classified and marketed.

Frequently Asked Questions

Does the Sunshine Act apply to independent distributors who don’t manufacture devices?

The Sunshine Act reporting obligation falls on “applicable manufacturers” — entities that manufacture covered drugs, devices, biologics, or medical supplies. An independent distributor that does not manufacture covered products is not directly subject to the reporting requirements. However, if the distributor makes payments to physicians on behalf of or at the direction of an applicable manufacturer, the manufacturer must report those payments. In practice, manufacturer-distributor agreements typically include provisions requiring the distributor to track and report transfers of value to covered recipients so the manufacturer can meet its Sunshine Act obligations. Independent reps should review their distribution agreements for these requirements.

What happens if a transfer of value is reported incorrectly?

CMS provides a review and dispute period each year before data publication. During this period, physicians can review reported payments and dispute any they believe are inaccurate. The manufacturer must respond and either confirm or correct the data. If the dispute is not resolved, both the manufacturer’s data and the physician’s dispute notation are published. Manufacturers that knowingly submit false information can face civil monetary penalties of up to $150,000 per payment, and up to $1 million for knowing failures to report. For reps, submitting inaccurate data to the manufacturer’s compliance system can create liability for the manufacturer and damage the rep’s relationship with both the manufacturer and the physician.

Are meals provided during surgical cases reportable?

Generally, yes. If a device rep provides food or beverages to a physician during a surgical case or in the facility during working hours, that is a transfer of value that must be tracked and reported. The context of the meal (whether it was during a case, in a physician lounge, or at a product evaluation) determines the category and attribution, but the reporting obligation applies regardless of the setting. Some manufacturers have policies limiting or prohibiting meals during surgical cases to avoid both Sunshine Act reporting and potential AKS issues. Check your manufacturer’s specific meal policy.

Can a physician opt out of having their payments reported?

No. The Sunshine Act does not provide physicians with an opt-out mechanism. If an applicable manufacturer makes a reportable transfer of value to a covered recipient, it must be reported regardless of the physician’s preference. The physician can dispute inaccurate data during the review period, and they can choose not to accept transfers of value from manufacturers to avoid having data reported. But they cannot accept the transfer and simultaneously prevent it from being reported. The transparency is mandatory and non-negotiable.